tradingkey.logo

Nxera Pharma Co Ltd - Nxera Pharma Achieves Development Milestone In Collaboration With Eli Lilly Targeting Metabolic Diseases

ReutersJun 1, 2025 11:32 PM

- Nxera Pharma Co Ltd 4565.T:

  • NXERA PHARMA CO LTD: NXERA PHARMA ACHIEVES DEVELOPMENT MILESTONE IN COLLABORATION WITH ELI LILLY TARGETING METABOLIC DISEASES

  • NXERA PHARMA CO LTD: UNDER TERMS OF AGREEMENT, NXERA IS ELIGIBLE TO RECEIVE DEVELOPMENT AND COMMERCIAL MILESTONES TOTALLING UP TO US$694 MILLION, PLUS TIERED ROYALTIES ON GLOBAL SALES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI